loader2
Partner With Us NRI

SMS Lifesciences India Ltd share Price Today

Company details

632.00
689.00
472.05
707.05
6M Return 31.05%
1Y Return 31.61%
Mkt Cap.(Cr) 204.40
Volume 6,989
Div Yield 0.22%
OI
-
OI Chg %
-
Volume 6,989

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500

SMS Lifesciences India Ltd shares SWOT Analysis

Strengths (8)

  • Strong Momentum: Price above short, medium and long term moving averages
  • Rising Net Cash Flow and Cash from Operating activity
  • Growth in Net Profit with increasing Profit Margin (QoQ)

Weakness (3)

  • Inefficient use of capital to generate profits - RoCE declining in the last 2 years
  • Degrowth in Revenue and Profit
  • Major fall in TTM Net Profit

Opportunity (1)

  • RSI indicating price strength

Threats (2)

  • High PE (PE > 40)
  • Increasing Trend in Non-Core Income

Resistance and support

R1 699.4
R2 722.7
R3 756.4
Pivot

665.72

S1 642.4
S2 608.7
S3 585.4
EMA SMA
623.2
599.5
577.4
565.3
617.9
595.5
566.0
541.1
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
USHA JAWAHARLAL KALRO Bulk Purchase 2023-06-05 539.22 16270 NSE
RAMACHANDRA NAIDU CHEREDDI Bulk Sell 2023-06-05 539.13 18103 NSE
USHA JAWAHARLAL KALRO Bulk Sell 2023-06-05 533.65 16225 NSE
Name Category Shares
ANNAPURNA TALLURI PROMOTER 24.56%
TVVSN MURTHY PROMOTER 15.88%
TVVSN MURTHY (HUF) (Karta - Mr.TVVSN Murthy) PROMOTER 7.98%
RAMESH BABU POTLURI PROMOTER 7.94%
VENKATA PRAVEEN TALLURI PROMOTER 3.65%
HIMA BINDU POTLURI PROMOTER 2.76%
SUDEEPTHI GOPINEEDI PROMOTER 2.61%
TRILOK POTLURI PROMOTER 2.58%
VAMSI KRISHNA POTLURI PROMOTER 2.42%

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

SMS Lifesciences India Ltd Stocks COMPARISON

Financials( in Cr) SMS Lifesciences India Ltd Sun Pharmaceuticals Industries Ltd Cipla Ltd Dr Reddys Laboratories Ltd Zydus Lifesciences Ltd
Price 676.15 1,620.55 1,496.95 6,157.90 1,007.35
% Change 5.10 1.02 2.30 1.88 0.77
Mcap Cr 204.40 388,824.23 120,856.26 102,719.31 101,964.37
Revenue TTM Cr 315.56 43,885.68 15,790.60 24,669.70 17,237.40
Net Profit TTM Cr 11.38 8,560.84 2,513.47 4,507.30 1,997.30
PE TTM 52.70 41.45 30.52 19.64 30.51
1 Year Return 31.61 64.78 68.33 37.28 109.04
ROCE 8.31 16.79 14.76 25.99 16.25
ROE 6.12 16.46 10.66 21.21 14.05
INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 168.61 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 29,068.81 33,709.58
LAST 3M 68,518.10 30,558.15
LAST 6M 130,081.93 64,349.19
LAST 12M 189,941.35 208,211.24

SMS Lifesciences India Ltd Information

Stock PE (TTM)
52.7
Promoter Holding
70.68%
Book Value
552.5826
ROCE
8.31%
ROE
6.12%
Description
  • The Company was incorporated originally as "Potluri Real Estate Private Limited" on 31May, 2006 for undertaking the activities of real estate business and the Company could not commence business activities andthe company`s name has been changed to "Potluri Packaging Industries Private Limited" on 6 November, 2013. The Company could not undertake any such activities, once again the company`s name has been changed to "SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company has become a wholly owned subsidiary company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016. Subsequently converted into a Public Company under the Companies Act, 2013 w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad. The Demerger Scheme sanctioned by the National Company Law Tribunal (NCLT) vide its order dated 15-05- 2017 received by the Company on 17-05-2017 has been implemented with appointed date as 01st April, 2016 as provided in the Scheme. Accordingly, the Semi Regulated Facilities i.e., Unit I, IV and V along with (i) premises situated at Industrial Estate, Sanath Nagar, Hyderabad; (ii) Industrial Development area, Jeedimetla, Hyderabad; (iii) Flat No. 417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad and (iv) Vacant Land admeasuring Ac 19.00 situated at Pharma City, Parawada, Vishakapatnam. Along with these assets the company has conferred with the liabilities mentioned in the books of the demerged company as on the appointed date. The Company allotted 30,23,287 equity shares of Rs.10 each to the shareholders of SMS Pharmaceuticals Limited (transferor Company) on 27 June, 2017 in pursuance of demerger scheme. Pursuant to the scheme of arrangement, the equity shares of the Company were listed in the National Stock Exchange of India Limited (NSE) and BSE Limited (BSE) w.e.f 17 August 2017. During the FY2018,the Board approved the acquisition of Mahi Drugs Private Limited (Mahi Drugs), a Bulk Drugs manufacturing Company located at Vishakhapatnam, Andhra Pradesh, as a wholly owned (100%) subsidiary of SMS Lifesciences India Limited by entering into a share purchase agreement. During the FY2019, the Company had achieved production of 2040 M.T of APIs and their Intermediaries in comparison with 1729 M.T for the FY 2017-18. During the year 2018-19, Mahi Drugs Private Limited became wholly owned subsidiary of the Company with effect from 17 September, 2018. During the year 2019-20, producation has declined from 1,364 M.T. of API`s and their intermediates in comparison with 2,040 M.T. for the previous year due to the new USFDA guidelines on Ranitidine HCL The Company has received the prestigious "India Pharma Bulk Drugs Company of the year award" on 5 March, 2020 at the 5th edition of India Pharma and Medical Device 2020 conference organized by FICCI in collaboration with Ministry of Chemical and fertilizers, Govt. of India.

Registered Address

Plot No 19-III Road No 71, Opp Bharatiya Vidya Bhavan PSc, Hyderabad, Telangana, 500096

Tel : 91-040-6628-8888
Email : info:smslife.in
Website : http://www.smslife.in
Registrar

Aarthi Consultants Pvt Ltd

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 540679
NSE Code : SMSLIFE
Book Closure Date (Month) : Sep
BSE Group : B
ISIN : INE320X01016

FAQ’s on SMS Lifesciences India Ltd Shares

You can buy SMS Lifesciences India Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy SMS Lifesciences India Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Mar 28, 2024 03:54 PM the closing price of SMS Lifesciences India Ltd was ₹ 676.15.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Mar 28, 2024 03:54 PM, the market cap of SMS Lifesciences India Ltd stood at ₹ 204.40.

The latest PE ratio of SMS Lifesciences India Ltd as of Mar 28, 2024 03:54 PM is 52.7

The latest PB ratio of SMS Lifesciences India Ltd as of Mar 28, 2024 03:54 PM is 0.82

The 52-week high of SMS Lifesciences India Ltd share price is ₹ 707.05 while the 52-week low is ₹ 472.05

Download Our

Download App
market app